Cinvanti
Active Ingredient(s): AprepitantFDA Approved: * November 9, 2017
Pharm Company: * HERON THERAPS INC
Category: Cancer
Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.[1] It may be used together with ondansetron and dexamethasone.[1] It is taken by mouth.[1] Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes.[1] Other sev... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.